Publication Drug resistance in leprosy: an update following 70 years of chemotherapy. Aubry A, Rosa SP, Chauffour A, et al. Infectious diseases now. 2022; Download PDF
Publication Spatio-temporal analysis of leprosy risks in a municipality in the state of Mato Grosso-Brazilian Amazon: results from the leprosy post-exposure prophylaxis program in Brazil. Machado LMG, dos Santos ES, Cavaliero A, et al. Infectious diseases of poverty. 2022; 11 (1) : 21. Download PDF
Publication Determining target populations for leprosy prophylactic interventions: a hotspot analysis in Indonesia. Taal A, Blok D, Handito A, et al. BMC infectious diseases. 2022; 22 (1) : 131. Download PDF
Publication Treatment and Evaluation Advances in Leprosy Neuropathy. Ebenezer G, Scollard D. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2021; Download PDF
Publication A 5-year evaluation of chemoprophylactic treatment in elementary school children with subclinical leprosy. Astari L, Sari N, Nanang K, et al. Biomedical reports. 2021; 15 (5) : 88. Download PDF
Publication Preventing leprosy with retrospective active case finding combined with single-dose rifampicin for contacts in a low endemic setting: results of the Leprosy post-exposure prophylaxis program in Cambodia Cavaliero A, Sao SA, Aerts A, et al. Elsevier BV. Acta Tropica. 2021; Download PDF
Publication Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: a systematic review and network meta-analysis of randomized controlled trials. Tawfik G, Biala M, Yousef Y, et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021; Download PDF
Publication Safety in administering medicines for neglected tropical diseases World Health Organization . World Health Organization. 2021; Download PDF
Publication Neglected tropical diseases and One Health: Gearing up against antimicrobial resistance to secure the safety of future generations World Health Organization . World Health Organization. 2021; Download PDF
Publication Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist's dilemma. Parajuli N, Poudyal Y. PLoS neglected tropical diseases. 2021; 15 (4) : e0009039. Download PDF
Publication Towards zero leprosy. Global leprosy (Hansen’s Disease) strategy 2021–2030 World Health Organization . 2021; Download PDF
Publication Leprosy incidence and risk estimates in a 33-year contact cohort of leprosy patients. Hacker MA, Sales A, Duppre NC, et al. Scientific reports. 2021; 11 (1) : 1947. Download PDF
Publication Leprosy post-exposure prophylaxis: innovation and precision public health. Moraes M, Duppre NC. The Lancet. Global health. 2021; 9 (1) : e8-e9. Download PDF
Publication A Systematic Review of the Importance of Chemoprophylaxis and Immunoprophylaxis in Subclinical Case of Leprosy that can Reduce the Incidence and the Transmission of Leprosy Mulianto N, Sari ADAP, Kariosentono H, et al. European Journal of Molecular & Clinical Medicine. 2020; 7 (11) : 709-715. Download PDF
Publication Global consultation of National Leprosy Programme managers, partners and affected persons on Global Leprosy Strategy 2021–2030: Report of the virtual meeting 26-30 October 2020 WHO/Department of control of neglected tropical diseases . World Health Organization. 2020; Download PDF
Publication Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis World Health Organization . World Health Organization. 2020; Download PDF
Publication A comprehensive research agenda for zero leprosy Steinmann P, Dusenbury C, Addiss D, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2020; Download PDF
Publication The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis Schoenmakers A, Mieras L, Budiawan T, et al. Informa UK Limited. Research and Reports in Tropical Medicine. 2020; Download PDF
Publication Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy. Lenz SM, Collins J, Ray N, et al. PLoS neglected tropical diseases. 2020; 14 (9) : e0008583. Download PDF
Publication Jopling's Handbook of Leprosy, 6/E Sardana K, Khurana A. CBS Publishers & Distributors. 2020; Download PDF
